Key F Inancial Inc Alaunos Therapeutics, Inc. Transaction History

Key F Inancial Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 29, 2021	BUY	$2.09 - $3.09 $7,701 - $11,386	3,685 New	3,685 $9,000
Q2 2020 Aug 07, 2020	SELL	$2.2 - $3.71 $8,107 - $13,671	-3,685 Closed	0 $0
Q1 2020 May 05, 2020	BUY	$1.9 - $4.98 $7,001 - $18,351	3,685 New	3,685 $9,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $424M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Key F Inancial Inc, based on Form 13F filings with the SEC.

Stay updated on Key F Inancial Inc with notifications on news.